Skip to main content
OpenTrials

Clinical trial condition

VHL-Associated Renal Cell Carcinoma

Explore clinical trials studying VHL-Associated Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

VHL-Associated Renal Cell Carcinoma trial results

Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NCT07300241

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations
  • NEO-811 Los Angeles Site Duarte, California, United States
  • NEO-811 San Diego Site San Diego, California, United States
  • NEO-811 Connecticut Site New Haven, Connecticut, United States
  • NEO-811 Chicago Site Zion, Illinois, United States
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

NCT03401788

Conditions
Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +14 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions